CUTLER BAY, Fla., Aug. 22, 2019 /PRNewswire/ -- Fortis College in Cutler Bay, part of a network of schools manag

NEW YORK, Aug. 22, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Nektar Therapeutics ("Nektar"  or the Company") (NASDAQ: NKTR) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Nektar securities bet

MINNEAPOLIS, Aug. 22, 2019 /PRNewswire/ -- Although it may sound harsh, odds are your organization's compliance program is boring your employees. But it doesn't have to. The newest book release from the Society of Corporate Compliance and Ethics & Health Care Compliance Association (SCCE & HCCA) can help you energize your training program.

BEER-SHEVA, Israel, Aug. 22, 2019 /PRNewswire/ -- MDClone announced today the closing of a $26 million Series B funding round led by health-tech venture capital fund aMoon, with additional funding from existing investors OrbiMed Israel Partners and Lightspeed Venture Partners. MDClone has built the first of its kind plat

NEW YORK, Aug. 22, 2019 /PRNewswire/ -- Preeminent eCommerce marketing platform Yotpo will present its inaugural customer conference

NEW YORK, Aug. 22, 2019 /PRNewswire/ -- In recognition that September is Ovarian Cancer Awareness Month, the Crown of Light diamond brand, sold exclusively at Diamonds International, is excited to continue their support towards bringing awareness about a disease that affects so many women worldwide. From September 1st to

SAN FRANCISCO, Aug. 22, 2019 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a clinical-stage biopharmaceutical company, today announced dosing of the first patient in its Phase 3 EMERGE efficacy trial of STS101 (dihydroergotamine (DHE) nasal powder) for the acute treatment of migraine. Satsuma's President and Chief Executive Offic

NEW YORK, Aug. 22, 2019 /PRNewswire/ -- Today, Fortune Magazine named

SAN CARLOS, Calif., Aug. 22, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-fr

MORRISTOWN, N.J., Aug. 22, 2019 /PRNewswire/ -- The National Cancer Institute (NCI) has designated Atlantic Health System as a National Community Oncology Research Program (NCORP) site of the Atlantic Health Cancer Consortium (AHCC).  As the first and only New Jersey-based NCORP, AHCC will help develop and implement NCI cancer preven